Check out our state-of-the-art medical cannabis cultivation facility in Portugal in this behind-the-scenes tour!
Because we take quality seriously, we control the full value chain of our products from growing to manufacturing and distribution
We have over 75 years of experience in botanical extraction and in manufacturing plant-based medicines.
We are fully committed to gathering and documenting evidence to support the therapeutic potential of cannabis-based medicines
Legalisierungsprozess
Cannabis legalisiert
Patients in focus: Patients do not suffer from their illnesses alone but also from the symptoms and burdens of coping with serious illness. The goal of our research is to develop cannabis-based products that have proven effective in relieving symptoms.
Because cannabis has historically not been cultivated at scale for pharmaceutical production, developing cannabis-based medicines that comply fully with EU quality standards, requires an investment in the full production value chain
Our best guarantee for reliable and secure supply for our pharmaceutical production
EXPERT aREA
Memberships
The VCA is the professional association for pharmacies supplying cannabis in Germany. It is focused on developing competence, offers further education and promotes the exchange of content between pharmacists, industry, science and politics. The declared goal of the VCA is to ensure an efficient and affordable supply of medical cannabis to patients in Germany.
The Federation of the Pharmaceutical Industry is the responsible industry association for research-oriented cannabis manufacturers. The BPI also represents the broad spectrum of the pharmaceutical industry on a national and international level. More than 270 companies have joined forces in the BPI.
The EUMCA acts as an authoritative voice of the medical cannabis industry, representing European manufacturers and suppliers of pharmaceutical-grade cannabis products. Its members are a diverse group of stakeholders.
Cooperation Partners
Avextra Pharma is cooperating with J. W. Goethe University in a preclinical research project. In the future, the scientific findings of this work will help to tailor the composition of cannabis-based products even better to the respective medical indication. In this way, we would like to meet the individual needs of patients in an evidence-based manner.
CESPU is a leading institute in Portugal in the field of pharmacy and toxicity. We collaborate on basic toxicology research.
Together with IPS, we operate Integro Medical Cannabis Clinics in Great Britain. This clinic meets the highest quality standards and primarily treats patients with severe pain symptoms.
With around 4,000 members, the German Society for Pain Medicine is the largest society of practising pain therapists in Europe. Since its foundation in 1984, the medical society has been committed to improving the care of patients with chronic pain. Avextra is a supporting partner in the DGS "Cannabis Initiative 2022 /23" which seeks to improve patient access to Cannabis-based medicines.